New Heart-Lung device could save kids with severe heart failure
NCT ID NCT06080074
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study tests a compact heart-lung machine called Cardiohelp in 50 children with severe heart failure. The device supports the heart for up to 30 days while kids recover or await a transplant. The trial also compares two blood thinners to see which causes fewer bleeding or clotting problems. The goal is to get the device FDA-approved for children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cardiohelp device (VA-ECMO) and blood thinners (heparin or bivalirudin)
- What this could lead to
- If successful, this could lead to FDA approval of the Cardiohelp device for longer-term use in children with severe heart failure, and identify a safer blood thinner for these patients.
- What could go wrong
- This is a Phase 2 trial with only 50 children, so results are preliminary. The device is used off-label, and risks like stroke, bleeding, and organ failure are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Health Dallas
RECRUITINGDallas, Texas, 95235, United States
-
Cuimc/Nyph
RECRUITINGNew York, New York, 10032, United States
-
Duke University Hospital
RECRUITINGDurham, North Carolina, 27710, United States
-
Lucile Packard Children's Hospital
RECRUITINGPalo Alto, California, 94304, United States
-
Seattle Children's Hospital
RECRUITINGSeattle, Washington, 98105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- Liver clues: a new way to stage heart amyloidosis?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- A website designed to steer teens with heart defects away from vaping
- Poles apart? nordic walking may outpace standard rehab for heart failure